IS5727A - Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness - Google Patents

Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness

Info

Publication number
IS5727A
IS5727A IS5727A IS5727A IS5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A IS 5727 A IS5727 A IS 5727A
Authority
IS
Iceland
Prior art keywords
ghs
serm
selective
growth hormone
skeletal muscle
Prior art date
Application number
IS5727A
Other languages
Icelandic (is)
Inventor
Zhu Ke Hua
Li Mei
Codetta Pan Lydia
Duane Thompson David
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of IS5727A publication Critical patent/IS5727A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS5727A 1998-06-16 2000-11-24 Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness IS5727A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8942498P 1998-06-16 1998-06-16
PCT/IB1999/000796 WO1999065488A1 (en) 1998-06-16 1999-05-03 Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty

Publications (1)

Publication Number Publication Date
IS5727A true IS5727A (en) 2000-11-24

Family

ID=22217565

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5727A IS5727A (en) 1998-06-16 2000-11-24 Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness

Country Status (29)

Country Link
EP (1) EP1085867A1 (en)
JP (1) JP2002518328A (en)
KR (1) KR20010052817A (en)
CN (1) CN1305378A (en)
AP (1) AP9901581A0 (en)
AR (1) AR018868A1 (en)
AU (1) AU3342099A (en)
BG (1) BG105128A (en)
BR (1) BR9911357A (en)
CA (1) CA2335112A1 (en)
CO (1) CO5070586A1 (en)
EA (1) EA200001189A1 (en)
GT (1) GT199900083A (en)
HR (1) HRP20000857A2 (en)
HU (1) HUP0102395A2 (en)
ID (1) ID26726A (en)
IL (1) IL139587A0 (en)
IS (1) IS5727A (en)
MA (1) MA26648A1 (en)
NO (1) NO20006381D0 (en)
OA (1) OA11569A (en)
PA (1) PA8472101A1 (en)
PE (1) PE20000633A1 (en)
PL (1) PL345064A1 (en)
SK (1) SK18902000A3 (en)
TN (1) TNSN99118A1 (en)
UY (1) UY25557A1 (en)
WO (1) WO1999065488A1 (en)
ZA (1) ZA993973B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004306A3 (en) * 1998-08-06 2000-06-07 Pfizer Products Inc. Estrogen agonists/antagonists
BR0113626A (en) * 2000-08-30 2003-06-17 Pfizer Prod Inc Sustained-Release Formulations for Growth Hormone Secretors
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
CN100548283C (en) * 2001-11-29 2009-10-14 Gtx公司 Osteoporosis prevention that androgen-deprivation causes and treatment
US7524866B2 (en) 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
CU23558A1 (en) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech COMPOUNDS ANALOG TO THE PEPTIDIC SECRETAGOGS OF THE GROWTH HORMONE
EP2644618B1 (en) 2007-02-09 2016-08-17 Ocera Therapeutics, Inc. tether intermediates for the synthesis of macrocyclic ghrelin receptor modulators

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (en) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)cis-6(S)-phenyl-5(R)-[4-(2-pyrrolidin-I-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol D-tartrate, a method of its preparation, method of THE treatment OF diseases medicated by agonists of estrogen and a pharmaceutical composition
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (en) * 1996-02-28 1997-06-26 Inc Pfizer COMBINED THERAPY FOR OSTEOPOROSIS

Also Published As

Publication number Publication date
TNSN99118A1 (en) 2005-11-10
EA200001189A1 (en) 2001-06-25
MA26648A1 (en) 2004-12-20
HRP20000857A2 (en) 2001-10-31
PL345064A1 (en) 2001-11-19
CA2335112A1 (en) 1999-12-23
AU3342099A (en) 2000-01-05
ID26726A (en) 2001-02-01
PA8472101A1 (en) 2000-09-29
BR9911357A (en) 2001-03-13
OA11569A (en) 2004-07-01
BG105128A (en) 2001-11-30
CN1305378A (en) 2001-07-25
PE20000633A1 (en) 2000-07-26
AR018868A1 (en) 2001-12-12
AP9901581A0 (en) 1999-06-30
WO1999065488A1 (en) 1999-12-23
GT199900083A (en) 2000-12-05
EP1085867A1 (en) 2001-03-28
JP2002518328A (en) 2002-06-25
SK18902000A3 (en) 2001-12-03
NO20006381L (en) 2000-12-14
ZA993973B (en) 2000-12-15
NO20006381D0 (en) 2000-12-14
UY25557A1 (en) 2001-01-31
HUP0102395A2 (en) 2001-11-28
CO5070586A1 (en) 2001-08-28
IL139587A0 (en) 2002-02-10
KR20010052817A (en) 2001-06-25

Similar Documents

Publication Publication Date Title
IS2595B (en) Protein blend and process for isolating protein mixture from muscle tissue
DK0946190T3 (en) Methods and Compositions for Stimulating Neurite Growth
EP1143987A4 (en) Natural composition and method for the treatment of sexual dysfunction
IL144524A0 (en) Method for simulation of human response to stimulus
IS2390B (en) Method of removing muscle meat from fish and equipment to perform that method
EP1136141A4 (en) Treating apparatus, treating method and method of treating soil
EP1071841A4 (en) Method and apparatus for countercurrent treatment of slurries
DK0898894T3 (en) Semi-automatic device for boning of piglet and method for boning of piglet using the same
IS5727A (en) Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone (GHS) to treat skeletal muscle weakness
IS4805A (en) Method of treatment and pharmaceutical composition
EP1166904A4 (en) Method for detoxification treatment of soil
DK3497A (en) Sustained release formulation of an animal growth hormone and process for its preparation
IS5691A (en) Treatment combinations of (selective) estrogen receptor (SERM) and growth hormone secretion (GHS) for the treatment of skeletal muscle weakness
GB9826812D0 (en) Method of water treatment using zeolite crystalloid coagulants
NO20011824D0 (en) Controlled release fertilizer mixtures and processes for their preparation
AUPP010397A0 (en) Method and composition for treatment of sexual dysfunction
IL147008A0 (en) Mixing apparatus and method of mixing
EP1296889A4 (en) Plasticizable mixture and method of using
NO982112L (en) Mixed dose mixture, of an angiotensin converting enzyme inhibitor and a calcium channel antagonist, method of preparation and use thereof in the treatment of cardiovascular diseases
BR9508718A (en) Establishment and method for segregation of ovarian tonic estrogen for extended therapeutic regimens
NO20032969D0 (en) Method of Screening for Progesterone Receptor Isoform-Specific Ligands and for Tissue Selective Progesterone Receptor Ligands
EP1009433A4 (en) Therapeutic composition and method of treatment
DK1244662T3 (en) Pyridazinoquinoline derivatives and method of treating pain
IS6428A (en) Method and mix to treat pain
PL335477A1 (en) Method of and apparatus for controlling operation of snow removing mixture spreader